Extracorporeal life support in thoracic emergencies—a narrative review of current evidence
Journal of Thoracic Disease · 2023-07 · 15 (7) · 4076-4089
DOI: 10.21037/jtd-22-1307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thoracic Disease, 2023-07. Verfasst von Anne Willers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objective: Resuscitative therapies for respiratory and cardiac failure are lifesaving and extended by using extracorporeal life support (ECLS) as mechanical circulatory support (MSC). This review informs the debate to identify the life-threatening thoracic emergencies in which patients may be cannulated for ECLS support.
Methods
An advanced search was performed in PubMed, Embase, Google Scholar, and references query, assessed in June 2022, identified 761 records. Among them, 74 publications in English were included in the current narrative review. Key Content and Findings: ECLS is an additional tool for organ support in life-threatening thoracic emergencies. It provides bridging to recovery or to decision about destination as definitive therapy, intervention, or surgery. Non-traumatic emergencies include mediastinal mass, acute lung injury (ALI), aspiration, embolisms, acute and chronic heart failure. However, based on the current evidence, trauma, and especially blunt thoracic trauma, is one of the main indications for ECLS use in thoracic emergencies, among others in chest wall fractures, blunt and penetrating lung injuries. ECLS use is always individualized to patient's needs, injury pattern and kind of organ failure, circulatory arrest inclusive, depending on if respiratory or cardiac and circulatory support is needed. Further, ECLS offers the possibility for fast volume resuscitation and rewarming, thus preventing the lethal of trauma: hypothermia, hypoperfusion and acidosis. Anticoagulation may be omitted for some hours or days. Interdisciplinary cooperation between the intensivists, surgeons, anesthesiologists, emergency medical services, an appropriately organized and trained staff, equipment resources and logistical planning are essential for successful outcomes.
Conclusions
ECLS use in selected life-threatening thoracic emergencies is increasing. The summarized findings appeal to policymakers, and we hope that our summary of recommendations may impact clinical practice and research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
- Department of General Surgery, Catharina Ziekenhuis Eindhoven, Eindhoven, The Netherlands.
- Department of Cardio-Thoracic Surgery, Heart & Vascular Center, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
- Department of Respiratory Medicine, Paracelsus Medical University, Nuremberg, Germany.
Zitieren
APA
Willers, A., Mariani, S., Maessen, J. M., Lorusso, R., & Swol, J. (2023). Extracorporeal life support in thoracic emergencies—a narrative review of current evidence. Journal of Thoracic Disease, 15(7), 4076-4089. https://doi.org/10.21037/jtd-22-1307
Vancouver
Willers A, Mariani S, Maessen JM, Lorusso R, Swol J. Extracorporeal life support in thoracic emergencies—a narrative review of current evidence. Journal of Thoracic Disease. 2023;15(7):4076-4089. doi:10.21037/jtd-22-1307
BibTeX
@article{Willers2023,
author = {Willers, Anne and Mariani, Silvia and Maessen, Jos M and Lorusso, Roberto and Swol, Justyna},
title = {Extracorporeal life support in thoracic emergencies—a narrative review of current evidence},
journal = {Journal of Thoracic Disease},
year = {2023},
volume = {15},
number = {7},
pages = {4076--4089},
doi = {10.21037/jtd-22-1307}
}
EUVIMED